Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetes risk.
Godsland
I F
IF
Wynn Division of Metabolic Medicine, Imperial College School of Medicine, National Heart and Lung Institute, London, UK.
Stevenson
J C
JC
D000279:Administration, Cutaneous; D000284:Administration, Oral; D003327:Coronary Disease / Q000517:prevention & control*; D004958:Estradiol / Q000008:administration & dosage* / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008875:Middle Aged; D017698:Postmenopause / Q000378:metabolism*; D011374:Progesterone / Q000008:administration & dosage* / Q000627:therapeutic use
D007328:Insulin; D011374:Progesterone; D004958:Estradiol